Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study

被引:0
|
作者
Arrospide, A. [1 ,2 ]
Sagardui, M. G. [1 ]
Larizgoitia, I. [1 ]
Iturralde, A. [1 ,3 ]
Moreda, A. [1 ]
Mar, J. [2 ,4 ,5 ]
机构
[1] Minist Hlth Basque Govt, Donostia San Sebastian Kalea 1, Vitoria 01010, Spain
[2] Biodonostia Hlth Res Inst, Econ Evaluat Chron Dis Res Grp, San Sebastian, Spain
[3] Osakidetza Basque Hlth Serv, Directorate Gen, Vitoria, Spain
[4] Debagoiena Integrated Hlth Org, Osakidetza Basque Hlth Serv, Arrasate Mondragon, Spain
[5] Kronikgune Inst Hlth Serv Res, Baracaldo, Spain
关键词
COVID-19; Vaccine; Vaccine booster; Effectiveness; Hospital admissions; Omicron; IMPACT;
D O I
10.1016/j.vaccine.2023.05.061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of the study was to assess the effect of a booster dose of COVID-19 vaccine on the rates of hospital ward and intensive care unit (ICU) admissions around the time of emergence of the Omicron variant in the Basque Country. A retrospective cohort population-based study was conducted. The population with any records related to COVID-19 vaccination up to 28 February 2022 was classified into four cohorts by vaccination status. For every cohort, the hospital ward and ICU admission rates were calculated for each day between November 2021 and February 2022. Generalized linear models with a negative binomial distribution were used to estimate the age-adjusted hospitalization rate ratio of the cohort of individuals who had received a booster compared to the other cohorts. The age-adjusted rates of hospital ward and ICU admissions were 70.4 % and 72.0 % lower, respectively, in the fully vaccinated plus booster group compared to the fully vaccinated but no booster group. Analysing changes in the 14-day admission incidence rates showed that as the prevalence of the Omicron variant increased, the corresponding rate ratios decreased. The immunity acquired with the booster dose allowed the hospital network to meet all the demand for hospitalization during a period of high incidence of COVID-19, despite the fact that vaccine protection decreased as the prevalence of the Omicron variant increased. (c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4274 / 4279
页数:6
相关论文
共 50 条
  • [21] Willingness of Saudi Adults to Receive a COVID-19 Vaccine Booster Dose
    Alshahrani, Najim Z. Z.
    Ridda, Iman
    Rashid, Harunor
    Alzahrani, Faris
    Othman, Lujain Mohammed Bin
    Alzaydani, Hassan Ali
    SUSTAINABILITY, 2023, 15 (02)
  • [22] Investigating the tendency to use COVID-19 vaccine booster dose in Iran
    Askarian, Mehrdad
    Kazerooni, AmirAli Rastegar
    Shayan, Zahra
    Karimzadeh, Parisa
    Movahedi, Mohammad
    Hatam, Nahid
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [23] Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance
    Sirison, Kanchanok
    Nittayasoot, Natthaprang
    Techasuwanna, Ranida
    Cetthakrikul, Nisachol
    Suphanchaimat, Rapeepong
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2023, 8 (02)
  • [24] Investigating the tendency to use COVID-19 vaccine booster dose in Iran
    Mehrdad Askarian
    AmirAli Rastegar Kazerooni
    zahra Shayan
    Parisa Karimzadeh
    Mohammad Movahedi
    Nahid Hatam
    BMC Health Services Research, 23
  • [25] Factors Associated with Not Receiving a Booster Dose of COVID-19 Vaccine in Peru
    Bendezu-Quispe, Guido
    Caira-Chuquineyra, Brenda
    Fernandez-Guzman, Daniel
    Urrunaga-Pastor, Diego
    Herrera-Anazco, Percy
    Benites-Zapata, Vicente A.
    VACCINES, 2022, 10 (08)
  • [26] Drivers of and Barriers to COVID-19 Vaccine Booster Dose Acceptance in Indonesia
    Harapan, Harapan
    Fathima, Raisha
    Kusuma, Hendrix Indra
    Anwar, Samsul
    Nalapraya, Widhy Yudistira
    Wibowo, Adityo
    Wati, Ketut Dewi Kumara
    Medina, Ayunda
    Defrita, Anna Hanifa
    Astri, Yesi
    Prasetyowati, Arie
    Nurfarahin, Nurfarahin
    Khusna, Afriyani
    Oktariana, Setya
    Anwar, Sarifuddin
    Yussar, Milza Oka
    Khotimah, Siti
    Nainggolan, Bahagia Willibrordus Maria
    Badri, Putri Rizki Amalia
    Argarini, Raden
    Winardi, Wira
    Indah, Rosaria
    Sallam, Malik
    Rajamoorthy, Yogambigai
    Wagner, Abram L.
    Mudatsir, Mudatsir
    VACCINES, 2022, 10 (12)
  • [27] The Omicron wave and the waning of COVID-19 vaccine effectiveness. Influence of vaccine booster and age on confirmed infection incidence
    Corral-Gudino, Luis
    Del-Amo-Merino, Maria Piedad
    Eiros-Bouza, Jose Maria
    Garcia-Cruces-Mendez, Jesus Fernando
    Gonzalez, Marta Dominguez-Gil
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 102 : 122 - 124
  • [28] Risk factors for COVID-19 hospitalisation after booster vaccination during the Omicron period: A French nationwide cohort study
    Turpin, Agathe
    Semenzato, Laura
    Le Vu, Stephane
    Jabagi, Marie-Joelle
    Bouillon, Kim
    Drouin, Jerome
    Bertrand, Marion
    Kanagaratnam, Lukshe
    Weill, Alain
    Dray-Spira, Rosemary
    Zureik, Mahmoud
    Botton, Jeremie
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (07)
  • [29] New Wave of COVID-19 Vaccine Opinions in the Month the 3rd Booster Dose Arrived
    Delcea, Camelia
    Cotfas, Liviu-Adrian
    Craciun, Liliana
    Molanescu, Anca Gabriela
    VACCINES, 2022, 10 (06)
  • [30] Effectiveness of the Booster Dose in Protecting against COVID-19, Colombia 2022
    Galvez, Jubby Marcela
    Pinzon-Rondon, Angela Maria
    Chaparro-Solano, Henry Mauricio
    Tovar-Romero, Hanna Valentina
    Ramirez-Prieto, Juliana
    Ortigoza-Espitia, Sergio Andres
    Ruiz-Sternberg, Angela Maria
    VACCINES, 2023, 11 (09)